PRESTIGE CONSUMER HEALTHCARE INC. Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) had Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax of $711.00 thousand as of 2026-03-31, per its 10-K filed 2026-05-14.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax
us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax · last filed 2026-05-14
- 2026-03-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $711.00K.
- 2025-03-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $836.00K.
- 2024-03-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $942.00K.
- 2023-03-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $930.00K.
| Period end | Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax | Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax as first filed |
|---|---|---|
| 2026-03-31 | $711.00K 10-K · filed 2026-05-14 | |
| 2025-03-31 | $836.00K 10-K · filed 2026-05-14 | |
| 2024-03-31 | $942.00K 10-K · filed 2026-05-14 | |
| 2023-03-31 | $930.00K 10-K · filed 2025-05-09 | |
| 2022-03-31 | $1.52M 10-K · filed 2024-05-15 | |
| 2021-03-31 | $1.20M 10-K · filed 2023-05-05 | |
| 2020-03-31 | -$73.00K 10-K · filed 2022-05-06 | $73.00K 10-K · filed 2020-05-08 |
| 2019-03-31 | $1.47M 10-K · filed 2021-05-07 | -$1.47M 10-K · filed 2019-05-13 |
| 2018-03-31 | -$1.41M 10-K · filed 2020-05-08 | |
| 2017-03-31 | $399.00K 10-K · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |